- (29 April 2022) Mainland oral drug put to the test in CUHK virus study (The Standard)
- (29 April 2022) 評估新冠藥效果 中大招2000患者 (Wen Wei Po) (Chinese version only)
- (29 April 2022) 中大試內地口服新藥 招2000患者臨牀研究 (Ming Pao) (Chinese version only)
- (28 April 2022) 中大進行香港首個新冠口服藥物臨床研究 擬全球招募2000名患者 (Sing Tao Daily) (Chinese version only)
- (27 April 2022) 揭腸微生態失衡 恐致「長新冠」 (Lion Rock Daily) (Chinese version only)
- (25 April 2022) 疫情｜中大醫科生夥義工到長洲探長者派物資：他們更需要慰問關心 (HK01) (Chinese version only)
- (23 April 2022) 【香港家書@20220423】香港中文大學香港中西醫結合醫學研究所所長 林志秀教授 (RTHK) (Chinese version only)
- (11 April 2022) Hong Kong team develops test for long Covid so recovered patients can tell if trouble lies ahead (SCMP)
- (11 April 2022) 腸道微生態 預測診斷長新冠 (am730) (Chinese version only)
- (11 April 2022) 9成患者服微生態配方 1年內無「長新冠」徵狀 (HKET) (Chinese version only)
